Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Ratchapong Netsrithong"'
Publikováno v:
Frontiers in Immunology, Vol 14 (2024)
Induced pluripotent stem cell (iPSC)-derived T (iT) cells represent a groundbreaking frontier in adoptive cell therapies with engineered T cells, poised to overcome pivotal limitations associated with conventional manufacturing methods. iPSCs offer a
Externí odkaz:
https://doaj.org/article/1cea8b1f6e4d45c6aeb86d85f0b7d3e2
Autor:
Siriwal Suwanpitak, Chutima Chanprasert, Ratchapong Netsrithong, Nattachet Plengvidhya, Pa-thai Yenchitsommanus, Methichit Wattanapanitch, Prapaporn Jungtrakoon Thamtarana
Publikováno v:
Stem Cell Research, Vol 63, Iss , Pp 102871- (2022)
Two heterozygous mutations (p.L475P in ZYG11A and p.E51K in GATA6) were identified in a family with autosomal dominant diabetes. ZYG11A-p.L475P was proposed as a causative mutation because of the complete segregation with hyperglycemia and the proven
Externí odkaz:
https://doaj.org/article/79cf7ff1688a46a09d71adf85602e96f
Autor:
Ratchapong Netsrithong, Siriwal Suwanpitak, Bootsakorn Boonkaew, Kongtana Trakarnsanga, Lung-Ji Chang, Chartsiam Tipgomut, Chinnavuth Vatanashevanopakorn, Kovit Pattanapanyasat, Methichit Wattanapanitch
Publikováno v:
Stem Cell Research & Therapy, Vol 11, Iss 1, Pp 1-15 (2020)
Abstract Background Human induced pluripotent stem cells (hiPSCs) offer a renewable source of cells for the generation of hematopoietic cells for cell-based therapy, disease modeling, and drug screening. However, current serum/feeder-free differentia
Externí odkaz:
https://doaj.org/article/9974968082df4a4a98ff0b7af1132e11
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Adoptive cell therapy (ACT) using chimeric antigen receptor (CAR) T cells holds impressive clinical outcomes especially in patients who are refractory to other kinds of therapy. However, many challenges hinder its clinical applications. For example,
Externí odkaz:
https://doaj.org/article/4f31d10c445a4c14a09c5fb2fb095002
Autor:
Bootsakorn Boonkaew, Lunnathaya Tapeng, Ratchapong Netsrithong, Chinnavuth Vatanashevanopakorn, Kovit Pattanapanyasat, Methichit Wattanapanitch
Publikováno v:
Stem Cell Research, Vol 31, Iss , Pp 79-82 (2018)
In this study, we used hair follicle keratinocytes for reprogramming. Collection of plucked hairs offers advantages over other somatic cells because no medical professional or operation room is required. Keratinocytes were isolated from plucked hairs
Externí odkaz:
https://doaj.org/article/c6759ee5bc194cc79c1469d9e01edb70
Autor:
Bootsakorn Boonkaew, Weeradee Thummavichit, Ratchapong Netsrithong, Chinnavuth Vatanashevanopakorn, Kovit Pattanapanyasat, Methichit Wattanapanitch
Publikováno v:
Stem Cell Research, Vol 30, Iss , Pp 34-37 (2018)
Human induced pluripotent stem cells (iPSCs) were generated from exfoliated renal epithelial cells isolated from a urine sample of a 31-year-old healthy woman. Epithelial cells were characterized for the expression of E-cadherin and reprogrammed usin
Externí odkaz:
https://doaj.org/article/34e6f6c2e9ac4ba79b75bd56b1494b00
Autor:
Methichit Wattanapanitch, Alisa Ritthaphai, Chanmi Park, Bootsakorn Boonkaew, Ratchapong Netsrithong, Kovit Pattanapanyasat, Pattarawan Limsiri, Chinnavuth Vatanashevanopakorn
Publikováno v:
Stem Cell Research, Vol 27, Iss , Pp 105-108 (2018)
We generated a human induced pluripotent stem cell (iPSC) line from caesarean section scar fibroblasts of a 33-year-old healthy woman using transgene-free Sendai viral vectors under feeder-free condition. The established iPSC line, designated as MUSI
Externí odkaz:
https://doaj.org/article/0545bde1390740b29a7b6eb731d315ca
Autor:
Ratchapong Netsrithong, Nutchanawan Promnakhon, Bootsakorn Boonkaew, Chinnavuth Vatanashevanopakorn, Kovit Pattanapanyasat, Methichit Wattanapanitch
Publikováno v:
Stem Cell Research, Vol 39, Iss , Pp - (2019)
Activated T lymphocytes of a healthy individual were reprogrammed to induced pluripotent stem cells (iPSCs) using Sendai viral vectors. Two iPSC lines, MUSIi011-A and MUSIi011-B, were established and characterized for the expression of pluripotent ma
Externí odkaz:
https://doaj.org/article/bb2c767e1610475cba4d1575ed4de34e
Autor:
Chinnavuth Vatanashevanopakorn, Chartsiam Tipgomut, Ratchapong Netsrithong, Bootsakorn Boonkaew, Lung-Ji Chang, Methichit Wattanapanitch, Siriwal Suwanpitak, Kongtana Trakarnsanga, Kovit Pattanapanyasat
Publikováno v:
Stem Cell Research & Therapy, Vol 11, Iss 1, Pp 1-15 (2020)
Stem Cell Research and Therapy, 11(1):481. BioMed Central
Netsrithong, R, Suwanpitak, S, Boonkaew, B, Trakarnsanga, K, Chang, L J, Tipgomut, C, Vatanashevanopakorn, C, Pattanapanyasat, K & Wattanapanitch, M 2020, ' Multilineage differentiation potential of hematoendothelial progenitors derived from human induced pluripotent stem cells ', Stem Cell Research and Therapy, vol. 11, no. 1, 481 . https://doi.org/10.1186/s13287-020-01997-w
Stem Cell Research & Therapy
Stem Cell Research and Therapy, 11(1):481. BioMed Central
Netsrithong, R, Suwanpitak, S, Boonkaew, B, Trakarnsanga, K, Chang, L J, Tipgomut, C, Vatanashevanopakorn, C, Pattanapanyasat, K & Wattanapanitch, M 2020, ' Multilineage differentiation potential of hematoendothelial progenitors derived from human induced pluripotent stem cells ', Stem Cell Research and Therapy, vol. 11, no. 1, 481 . https://doi.org/10.1186/s13287-020-01997-w
Stem Cell Research & Therapy
Background Human induced pluripotent stem cells (hiPSCs) offer a renewable source of cells for the generation of hematopoietic cells for cell-based therapy, disease modeling, and drug screening. However, current serum/feeder-free differentiation prot
Autor:
Siriwal, Suwanpitak, Nutchanawan, Promnakhon, Ratchapong, Netsrithong, Methichit, Wattanapanitch
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 2454
One of the major obstacles for adoptive cell transfer (ACT) of T cells is the loss of effector function and proliferative ability of isolated antigen-specific T cells after prolonged ex vivo expansion. To overcome this issue, induced pluripotent stem